Official ESCRS | European Society of Cataract & Refractive Surgeons
Vienna 2018 Delegate Registration Programme Exhibition Virtual Exhibition Satellites 2018 Survey


escrs app advert

In vitro activity of moxifloxacin against conjunctival flora

Search Title by author or title

Session Details

Session Title: Infections

Session Date/Time: Sunday 23/09/2018 | 16:30-18:00

Paper Time: 17:00

Venue: Room A3, Podium 3

First Author: : S.Edakhlon INDIA

Co Author(s): :    A. Kumar V   G. S.Pillai                 

Abstract Details


To study the in vitro activity of Moxifloxacin against conjunctival flora in patients undergoing cataract surgery.


Comtrust Charitable Trust Eye Hospital, Thalassery, Kerala, India


Conjunctival swab was taken from 480 patients who were posted for cataract surgery between November 2016 and February 2018 . Culture and sensitivity was done using these samples. Moxifloxacin resistance was studied in samples which grew bacteria.


181 samples grew Coagulase negative Staphylococcus of which 52 (28.72%) were resistant to Moxifloxacin , 39 samples grew Staphylococcus aureus of which 18 (46.15%) were resistant to Moxifloxacin.


There is a high incidence of resistance to moxifloxacin in organisms grown from conjunctival sac. With such a high incidence of resistance, Moxifloxacin may not be a good choice antibiotic either as preoperative topical prophylaxis or as intracameral injection to prevent postoperative endophthalmitis.

Financial Disclosure:


Back to previous